Product
|
linaclotide
- Brand:NO
- Model:1G,10G,1KG,5KG,25KG
- Purity:98%
- Cas:851199-59-2
- Createtime: 2026-07-02
- Updatetime: 2026-07-16
Product Details
| useage | FOR R&D RESEARCH USE |
| deliveryInfo | |
| appearance | white to off white powder |
| aliasen | |
| supplyCapacity | 50000000KG/Year |
| harbor | SHENZHEN |
| minorder | 1G |
Professional Product Parameters: CAS 851199-59-2 (Linaclotide )
1. Basic Identification
- CAS No.:851199-59-2 (free peptide); acetate salt is commonly used in formulations
- Product Name:Linaclotide ; Acetate Linaclotide
- IUPAC Name:L-Tyrosine, L-cysteinyl-L-cysteinyl-L-α-glutamyl-L-tyrosyl-L-cysteinyl-L-cysteinyl-L-asparaginyl-L-prolyl-L-alanyl-L-cysteinyl-L-threonylglycyl-L-cysteinyl-, cyclic (1→6),(2→10),(5→13)-tris(disulfide)
- Peptide Sequence:H-Cys1-Cys2-Glu3-Tyr?-Cys?-Cys?-Asn?-Pro?-Ala?-Cys1?-Thr11-Gly12-Cys13-Tyr1?-OH (disulfide bonds: Cys1?Cys?, Cys2?Cys1?, Cys??Cys13)
- Synonyms:Linaclotide acetate; Linaclotidum; Linares; Zelnorm (brand name)
- MDL:MFCD16217356
- InChIKey:KXGCNMMJRFDFNR-VRMHCMCOSA-N
- SMILES:CC1C(=O)NC2CSSCC3C(=O)NC(C(=O)NC(C(=O)NC(CSSCC(NC(=O)CNC(=O)C(NC2=O)C(C)O)C(=O)NC(CC4=CC=C(C=C4)O)C(=O)O)C(=O)NC(CSSCC(C(=O)N3)N)C(=O)NC(C(=O)N5CCCC5C(=O)N1)CC(=O)N)CC6=CC=C(C=C6)O)CCC(=O)OMOLNOVA
2. Chemical Data
- Molecular Formula:C??H??N??O??S?
- Molecular Weight:1526.74 g/mol (exact mass: 1525.39 Da)
- Elemental Analysis:C 46.40%, H 5.21%, N 13.76%, O 22.01%, S 12.62%
- Density:1.60 g/cm3 (predicted)
- pKa:3.05 ± 0.10 (predicted)
- LogP:-2.89 (calculated)
- TPSA:627.50 ?2
- H?Bond Donors:21; H?Bond Acceptors:36
- Rotatable Bonds:42
3. Physical & Chemical Properties
- Appearance:White to off?white amorphous powder (acetate salt)
-
Solubility:
- Water:~20 mg/mL (13.10 mM, soluble with heating)
- DMSO:~50 mg/mL (32.75 mM, soluble with heating)
- Methanol:slightly soluble (heated); insoluble in hexane, ether
- Melting Point:231–235 °C (decomposition)
- Boiling Point:2045.0 ± 65.0 °C (predicted)
- pH (1% aq. acetate):4.5–6.5
- Stability:Hygroscopic; sensitive to light, heat, and oxidation; aqueous solutions unstable, prepare fresh
- Storage:-20 °C (long?term); 2–8 °C (short?term); sealed, dry, light?proof, inert gas protection
4. Product Specifications (Typical)
- Purity:≥98.0% (HPLC); ≥99.0% (API grade)
- Single Impurity:≤1.0%
- Peptide Content:≥80.0%
- Acetate Content:5.0%–12.0%
- Moisture:≤10.0%
- Heavy Metals:≤10 ppm; Pb ≤0.5 ppm, Cd ≤2.5 ppm, Hg ≤1.5 ppm, As ≤0.15 ppm
- Residue on Ignition:≤1.0%
- Grade:Research grade / Pharmaceutical API grade
- Packing:1 mg, 5 mg, 10 mg, 25 mg, 100 mg, 1 g (lyophilized, aluminum foil bag); bulk packaging
5. Biological Function & Applications
- Mechanism:Potent, selective agonist of guanylate cyclase?C (GC?C) in intestinal epithelium; increases cGMP, promotes chloride/bicarbonate secretion, softens stool, and reduces visceral hypersensitivity
-
Core Activity:
- FDA?approved for irritable bowel syndrome with constipation (IBS?C) and chronic idiopathic constipation (CIC)
- Enhances intestinal fluid secretion and motility; reduces abdominal pain
-
Applications
- Pharmaceutical API
- Research tool for gastrointestnal physiology, GC?C signaling, and visceral pain
- Intermediate for peptide drug development
6. Safety & Handling
- GHS Classification:Acute Tox. 4 (oral); not a hazardous substance for skin/eye contact
- Handling:Avoid inhalation; use in fume hood; wear PPE (gloves, goggles)
- Disposal:Dispose per local chemical waste regulations
- Note:For research and pharmaceutical use only; unauthorized human administration is prohibited
